Autoimmune markers in patients with multiple sclerosis

by Lim, T.T., Nazrulhisham, N., Looi, I., Eow, G.B., Chong, H.T., Tan, C.T.
Published 2010

CHIMES-I: Sub-group analyzes of the effects of NeuroAiD according to baseline brain imaging characteristics among patients randomized in the CHIMES study

by Navarro, J.C., Chen, C.L.H., Lagamayo, P.D.J., Geslani, M.B., Eow, G.B., Poungvarin, N., de Silva, A., Wong, L.K.S., Venketasubramanian, N.
Published 2016

PARK16 is associated with PD in the Malaysian population

by Gopalai A.A., Ahmad-Annuar A., Li H.-H., Zhao Y., Lim S.-Y., Tan A.H., Lim T.T., Eow G.B., Santhi P., Shanthi V., Norlinah M.I., Aziz Z.A., Lim S.K., Tan C.T., Tan E.-K.
Published 2018

LRRK2 G2385R and R1628P Mutations Are Associated with an Increased Risk of Parkinson's Disease in the Malaysian Population

by Gopalai A.A., Lim S.-Y., Chua J.Y., Tey S., Lim T.T., Mohamed Ibrahim N., Tan A.H., Eow G.B., Abdul Aziz Z., Puvanarajah S.D., Viswanathan S., Looi I., Lim S.K., Tan L.P., Chong Y.B., Tan C.T., Zhao Y., Tan E.K., Ahmad-Annuar A.
Published 2018

Effect of Combined Treatment with MLC601 (NeuroAiDTM) and Rehabilitation on Post-Stroke Recovery: The CHIMES and CHIMES-E Studies

by Suwanwela N.C., Chen C.L.H., Lee C.F., Young S.H., Tay S.S., Umapathi T., Lao A.Y., Gan H.H., Baroque A.C., Navarro J.C., Chang H.M., Advincula J.M., Muengtaweepongsa S., Chan B.P.L., Chua C.L., Wijekoon N., De Silva H.A., Hiyadan J.H.B., Wong K.S.L., Poungvarin N., Eow G.B., Venketasubramanian N.
Published 2019

Prognostic factors and pattern of long-term recovery with MLC601 (NeuroAiD™) in the Chinese medicine NeuroAiD efficacy on stroke recovery - Extension study

by Venketasubramanian, N, Lee, C.F, Young, S.H, Tay, S.S, Umapathi, T, Lao, A.Y, Gan, H.H, Baroque, A.C, Navarro, J.C, Chang, H.M, Advincula, J.M, Muengtaweepongsa, S, Chan, B.P.L, Chua, C.L, Wijekoon, N, De Silva, H.A, Hiyadan, J.H.B, Suwanwela, N.C, Wong, K.S.L, Poungvarin, N, Eow, G.B, Chen, C.L.H
Published 2020